Advisory Board of This Issue (December 2017)Abdulahad Doğan, TurkeyAhmet Emre Eşkazan, TurkeyAhmet Muzaffer Demir, TurkeyAkif Selim Yavuz, TurkeyAnıl Tombak, TurkeyBülent Eser, TurkeyBurhan Engin, TurkeyCem Ar, TurkeyChloe Anthlas, UKDilber Talia İleri, TurkeyDushyant Kumar, IndiaDüzgün Özatlı, TurkeyEbru Koca, TurkeyEmre Tekgündüz, TurkeyEngin Özçivici, TurkeyErdal Karaöz, TurkeyErdal Kurtoğlu, TurkeyEren Altun, TurkeyGraeme Quest, CanadaHale Ören, TurkeyHandan Dinçaslan, TurkeyHüseyin Onay, TurkeyJames Yu, USAJamile Shammo, USAJansen Seheult, USAJohn M. Bennett, USAKanjaksha Ghosh, IndiaMahmut Bayık, TurkeyMajid Shahabi, IranMaria Papaioannou, GreeceMehmet Sönmez, TurkeyMelih Aktan, TurkeyMeral Beksaç, TurkeyMichael Grever, USAMüge Sayitoğlu, TurkeyMutlu Arat, TurkeyNader Cohan, IranNejat Akar, TurkeyOliver Karanfılski, MacedoniaPoojan Agarwal, IndiaRajat Kumar Agarwal, IndiaRejin Kebudi, TurkeyRosemary Sparrow, AustraliaRuchi Gupta, IndiaRümeyza Kazancıoğlu, TurkeySema Anak, TurkeySevil Çatal, TurkeySigbjørn Berentsen, NorwaySujata Mallick, IndiaTamar Tadmor, IsraelTiraje Celkan, TurkeyTürkan Patıroğlu, TurkeyUjjwayini Ray, IndiaÜmit Yavuz Malkan, TurkeyVildan Güngörer, TurkeyVildan Özkocaman, TurkeyVolkan Hazar, TurkeyYahya Büyükaşık, TurkeyYüksel Aliyazıcıoğlu, Turkey
REVIEWDOI: 10.4274/tjh.2017.0197Turk J Hematol 2017;34:282-288The Scope of Kidney Affection in Monoclonal Gammopathies at AllLevels of Clinical SignificanceMonoclonal Gammopatilerin Her Klinik Evresinde Böbrek Etkilenim PaternleriŞadiye Mehtat Ünlü 1 , Hayri Özsan 2 , Sülen Sarıoğlu 11Dokuz Eylül University Faculty of Medicine, Department of Pathology, İzmir, Turkey2Dokuz Eylül University Faculty of Medicine, Department of Hematology, İzmir, TurkeyAbstractMultiple myeloma (MM) is one of the most important clonal malignantplasma cell disorders and renal involvement is associated with poorprognosis. Although there are several reasons for renal impairmentin MM, the main cause is the toxic effects of monoclonal proteins.Although cast nephropathy is the best known and unchallengeddiagnosis for hematologists and pathologists, the renal effects ofmonoclonal gammopathy can be various. Monoclonal gammopathyof renal significance was proposed by the International Kidneyand Monoclonal Gammopathy Research Group for renal lesions inmonoclonal gammopathy in recent years. Renal lesions in monoclonalgammopathy can be grouped as follows: light chain (cast) nephropathy,acute tubular injury/necrosis, tubulointerstitial nephritis, amyloidosis,monoclonal Ig deposition diseases, immunotactoid glomerulopathy,type I cryoglobulinemia, proliferative glomerulonephritis withmonoclonal IgG deposits, C3 glomerulopathy with monoclonalgammopathy, and crystal-storing histiocytosis, considering theprevious and new terminology. In this study, renal involvement ofmonoclonal gammopathies, in terms of previous and new terminology,was reviewed.Keywords: Monoclonal gammopathy of renal significance, Plasmacell disorders, Multiple myeloma, Renal involvement, Kidney, CastnephropathyÖzMultipl miyelom (MM) malign plazma hücre hastalıklarının enönemlilerinden biridir ve böbrek tutulumu kötü prognozla ilişkilidir.Multipl miyelomda böbrek fonksiyonunu etkileyecek çeşitli faktörlerbulunmakla birlikte ana etken monoklonal proteinlerin toksik etkisidir.Monoklonal gammopatilerde böbrek tutulumları içinde hematologve patologlar tarafından en iyi bilinen ve tanısı sorunsuz olan “kastnefropatisi” olmakla birlikte çok farklı tutulum tipleri olabilir. Yakınzamanda “International Kidney and Monoclonal GammopathyResearch Group” tarafından, monoklonal gammopatilerdeki böbrektutulumlarını bir çatı altında toplayan “renal öneme sahip monoklonalgammopati” terimi önerildi. Monoklonal gammopatilerdeki böbreklezyonları, önceki ve yeni terminoloji uyarınca; hafif zincir kastnefropati, akut tübüler zedelenme/nekroz, tubulointerstisyelnefrit, amiloidoz, monoklonal Ig depo hastalıkları, immünotaktoidglomerülopati, tip I kriyoglobulinemi, monoklonal IgG depozitiilişkili proliferatif glomerülonefrit, monoklonal gammopati ilişkili C3glomerülopati ve kristal/histiyosit depo hastalığı olarak gruplanabilir.Bu makalede, monoklonal gammopatilerdeki böbrek tutulumu yeni veönceki terminolojiler gözden geçirildi.Anahtar Sözcükler: Renal öneme sahip monoklonal gammopati,Plazma hücre hastalıkları, Multipl miyelom, Böbrek tutulumu, Böbrek,Kast nefropatiIntroductionEach specific immunoglobulin (Ig) molecule, which is synthesizedby plasma cells, includes two identical heavy chains and twolight chains (LCs). There are 5 types of heavy chains (ϒ/α/μ/δ/Є),and immunoglobulins get their names (IgG, IgA, IgM, IgD, IgE)according to these, while there are 2 types of LC (К/λ). Eachheavy chain and LC has constant domains and variable domains.Variable domains include the antigen-binding region. Heavychains and LCs are synthesized independently of each other andfinally unite in the endoplasmic reticulum, and the structurecalled immunoglobulin is unified here [1,2].Normally, LCs are freely filtered through the glomerular basalmembrane because they are low-molecular-weight proteinsand are reabsorbed by the proximal tubules, endocytosed andcatabolized in the lysosome. After the catabolization process,their amino acids return to the circulation. There are cubilinmegalinreceptors on the brush-border of proximal tubular cells,which are very important for the control of LC endocytosis.©Copyright 2017 by Turkish Society of HematologyTurkish Journal of Hematology, Published by Galenos Publishing HouseAddress for Correspondence/Yazışma Adresi: Şadiye Mehtat ÜNLÜ, M.D.,Dokuz Eylül University Faculty of Medicine, Department of Pathology, İzmir, TurkeyPhone : +90 232 412 34 15E-mail : mehtat.unlu@deu.edu.tr ORCID-ID: orcid.org/0000-0002-7170-7594Received/Geliş tarihi: May 18, 2017Accepted/Kabul tarihi: August 22, 2017282
- Page 1 and 2: Volume 34 Issue 4 December 2017 80
- Page 3 and 4: Contact InformationEditorial Corres
- Page 5 and 6: TURKISH JOURNAL OF HEMATOLOGYINSTRU
- Page 7 and 8: subject may be posited. Do not publ
- Page 9 and 10: the questions. You may copy and pas
- Page 11: 352 Giant Intracranial Solitary Pla
- Page 15 and 16: Ünlü ŞM, et al: The Scope of Kid
- Page 17 and 18: Ünlü ŞM, et al: The Scope of Kid
- Page 19 and 20: Ünlü ŞM, et al: The Scope of Kid
- Page 21 and 22: Levy I and Tadmor T: Time to Cure H
- Page 23 and 24: Öngören Ş, et al: First-Line Tre
- Page 25 and 26: Öngören Ş, et al: First-Line Tre
- Page 27 and 28: Öngören Ş, et al: First-Line Tre
- Page 29 and 30: Öngören Ş, et al: First-Line Tre
- Page 31 and 32: RESEARCH ARTICLEDOI: 10.4274/tjh.20
- Page 33 and 34: Rezaei N, et al: FLT3 and NPM1 Muta
- Page 35 and 36: Rezaei N, et al: FLT3 and NPM1 Muta
- Page 37 and 38: Rezaei N, et al: FLT3 and NPM1 Muta
- Page 39 and 40: Menteşe A, et al: Serum Anti-Carbo
- Page 41 and 42: Menteşe A, et al: Serum Anti-Carbo
- Page 43 and 44: Menteşe A, et al: Serum Anti-Carbo
- Page 45 and 46: RESEARCH ARTICLEDOI: 10.4274/tjh.20
- Page 47 and 48: Gencer EB, et al: Phenotypical Anal
- Page 49 and 50: Gencer EB, et al: Phenotypical Anal
- Page 51 and 52: Gencer EB, et al: Phenotypical Anal
- Page 53 and 54: Sarıtürk Ç, et al: Visual Inform
- Page 55 and 56: Sarıtürk Ç, et al: Visual Inform
- Page 57 and 58: Sarıtürk Ç, et al: Visual Inform
- Page 59 and 60: RESEARCH ARTICLEDOI: 10.4274/tjh.20
- Page 61 and 62: Hsieh C and Rajashekharaiah V, Infl
- Page 63 and 64:
Hsieh C and Rajashekharaiah V, Infl
- Page 65 and 66:
RESEARCH ARTICLEDOI: 10.4274/tjh.20
- Page 67 and 68:
Qian H, et al: Antioxidants, Novel
- Page 69 and 70:
Qian H, et al: Antioxidants, Novel
- Page 71 and 72:
BRIEF REPORTDOI: 10.4274/tjh.2017.0
- Page 73 and 74:
Zengin E, et al: Infection-Related
- Page 75 and 76:
Zengin E, et al: Infection-Related
- Page 77 and 78:
Yıldıran A, et al: HSC Transplant
- Page 79 and 80:
Yıldıran A, et al: HSC Transplant
- Page 81 and 82:
IMAGES IN HEMATOLOGYDOI: 10.4274/tj
- Page 83 and 84:
IMAGES IN HEMATOLOGYDOI: 10.4274/tj
- Page 85 and 86:
IMAGES IN HEMATOLOGYDOI: 10.4274/tj
- Page 87 and 88:
LETTERS TO THE EDITORTurk J Hematol
- Page 89 and 90:
LETTERS TO THE EDITOR Turk J Hemato
- Page 91 and 92:
LETTERS TO THE EDITOR Turk J Hemato
- Page 93 and 94:
LETTERS TO THE EDITOR Turk J Hemato
- Page 95 and 96:
LETTERS TO THE EDITOR Turk J Hemato
- Page 97 and 98:
LETTERS TO THE EDITOR Turk J Hemato
- Page 99 and 100:
LETTERS TO THE EDITOR Turk J Hemato
- Page 101 and 102:
LETTERS TO THE EDITOR Turk J Hemato
- Page 103 and 104:
LETTERS TO THE EDITOR Turk J Hemato
- Page 105 and 106:
LETTERS TO THE EDITOR Turk J Hemato
- Page 107 and 108:
LETTERS TO THE EDITOR Turk J Hemato
- Page 109 and 110:
LETTERS TO THE EDITOR Turk J Hemato
- Page 111 and 112:
LETTERS TO THE EDITOR Turk J Hemato
- Page 113 and 114:
AUTHOR INDEX 201734 th Volume Index
- Page 115 and 116:
AUTHOR INDEX 2017Serkan Güvenç...
- Page 117 and 118:
SUBJECT INDEX 2017Status epilepticu
- Page 119 and 120:
SUBJECT INDEX 2017Chronic lymphocyt
- Page 121 and 122:
SUBJECT INDEX 2017Single nucleotide
- Page 123 and 124:
SUBJECT INDEX 2017Megakaryocytic em